May 28, 2014 11:45 AM EDT
German Drug Manufacturer Agrees to $650 Million Settlement for Blood Thinner Medication
The Boehringer Ingelheim group is headquartered in Ingelheim, Germany and is one of the world’s 20 leading pharmaceutical companies. On Wednesday, the German drugmaker announced a settlement with the U.S. regarding their drug Pradaxa.